vRad announces new patent for escalating radiology procedures through AI

vRad, a MEDNAX company, announced this week that it has secured a patent for using artificial intelligence (AI) to escalate high-priority radiology procedures.

The patent, officially titled “Medical Evaluation Machine Learning Workflows and Processes,” is vRad’s 18th overall.

Shannon Werb, the company’s president and chief operating officer, said in a prepared statement that the patent will help vRad, and MEDNAX, provide patients with high-quality care.

“This latest patent highlights the value MEDNAX radiology, powered by the vRad platform, creates by providing better overall patient care,” Werb said. “We are focusing our artificial intelligence strategy on helping doctors do a better job by removing obstacles and elevating their reading experience where their technical efficiency and interpretive accuracy are maximized. Our goal is to improve overall interpretation accuracy, speed, and quality so that our network of radiologists can focus on what they do best—taking great care of patients.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.